Many new gene therapy treatments aren’t as profitable as predicted. But the reasons why don’t quite fit Goldman Sachs’ ...
AV Laboratories is redefining the future of skincare by translating decades of advanced biotechnology research into clinically driven formulations designed for everyday use. Rooted in expertise ...
From my colleague Andrew Joseph: One of the open questions about the future of Sanofi as Belén Garijo takes over as CEO this ...
Eye injection of fatty acid restores vision in elderly mice, showing promising results for human use
Injecting a fatty acid that is used to make very long fat molecules into the eyes of elderly mice improved their vision for up to a month, indicating that the natural compound could potentially be ...
-- PanGIA Analysis System, a novel machine learning platform for non-invasive diagnosis of oral cancer through an oral sample -- PanGIA Analysis System, a novel machine learning platform for ...
Edesa Biotech Inc. (NASDAQ:EDSA) is one of the 10 Unstoppable Stocks That Could Double Your Money. Edesa Biotech Inc. (NASDAQ ...
Biotech Labz Supply has announced an exciting expansion of its product line, focusing on research peptides that are gaining attention in the scientific community. As a leading supplier of high-quality ...
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
The International Space Station’s Expedition 74 crew conducted pioneering biotech experiments this week, including stem cell and DNA nanotherapy studies aimed at improving human health and supporting ...
The Fight of Our Lives highlights biotech’s impact on patient lives in both the short- and long-term, urging continued ...
Biotech Labz Supply has revealed an exciting enhancement of its product range, concentrating on research peptides that are gaining traction within the scientific community. As a prominent provider of ...
UGC Chairman Professor Dr Mamun Ahmed said biotechnology curricula are still overly theoretical and not aligned with industry needs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results